Guidance
Measles and Measles-Rubella (MR) Vaccine Five-Dose Vial Presentation - Fact Sheet 2022 - 2023
Compiled UNICEF and WHO insights on the 5-dose presentation (e.g., estimated reductions in wastage, estimated required cold storage).
Languages
- English
Publication year
2022
Type
Categories
Diseases
MCV5 PHASE 1
This resource appears in the following Hot Topic page:
The resource is included in the following table:
| Title | Author | Year | Type | Language |
|---|---|---|---|---|
| Experiences with the MCV 5-dose Switch from Africa’s EPI | UNICEF | 2024 | Case study | English |
| MCV 5-dose 2-Pager | Linksbridge | 2026 | Guidance | English |
| MCV 5-dose Option Overview | Linksbridge | 2026 | Guidance | English |
| MCV 5-dose Research and Resources | Linksbridge | 2022 | Report | English |
| Measles and Measles-Rubella (MR) Vaccine Five-Dose Vial Presentation - Fact Sheet 2022 - 2023 | UNICEF, World Health Organization (WHO) | 2022 | Guidance | English |
